Business Context and Reporting Period
Company: Chemed Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2005
Business Overview: Chemed operates primarily through two segments: VITAS (hospice services) and Roto-Rooter (plumbing and drain cleaning). The 2005 results reflect the full quarter of consolidated VITAS operations, acquired in February 2004.
Key Financial Metrics
| Metric (in thousands) | Q1 2005 | Q1 2004 |
|---|---|---|
| Service Revenues and Sales | $218,637 | $120,340 |
| Net Income | $8,116 | $(7,110) |
| Income from Continuing Operations | $7,905 | $(7,256) |
| Diluted EPS | $0.63 | $(0.65) |
| Cash and Cash Equivalents (End of Period) | $8,557 | $43,036 |
| Long-Term Debt | $234,738 | $279,510 |
| Net Cash Used by Operating Activities | $(4,148) | $(12,951) |
| Gross Margin | 30.0% | 34.5% |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 82% ($98.3 million) year-over-year, driven primarily by the inclusion of VITAS for the full quarter (compared to 37 days in 2004) and organic growth in Roto-Rooter.
- Profitability Turnaround: The company moved from a net loss of $7.1 million in Q1 2004 to a net income of $8.1 million in Q1 2005. This shift was aided by lower Long-Term Incentive Plan (LTIP) expenses and higher operating income from VITAS.
- Debt Reduction: Total long-term debt decreased by $55.7 million to $236.0 million. The company prepaid $110 million of Floating Rate Notes and recorded a $3.97 million loss on extinguishment of debt.
- Liquidity: Cash and cash equivalents declined by $62.9 million to $8.6 million, primarily due to debt repayment and timing differences in Medicare receivables.
- Margin Compression: Consolidated gross margin decreased to 30.0% from 34.5%, largely because VITAS (which has a lower margin profile) represented a larger percentage of total revenue (67% vs. 42% in 2004).
Outlook, Risks, and Unusual Items
- Stock Split: A 2-for-1 stock split was approved on March 11, 2005, payable May 11, 2005. Historical per-share data will be restated retroactively.
- Accounting Changes: The company accelerated the vesting of all unvested stock options in March 2005 to mitigate the impact of the new SFAS No. 123R standard (effective Jan 1, 2006), incurring a $215,000 pretax charge.
- Legal Contingencies:
- OIG Investigation: The Office of Inspector General served civil subpoenas on VITAS regarding Medicare/Medicaid billing practices. The outcome and financial impact are currently unpredictable.
- Class Action Litigation: A tentative resolution was reached regarding a class action lawsuit against Roto-Rooter in Illinois; a $3.1 million accrual was made in Q4 2004.
- Discontinued Operations: Service America was sold in May 2005. Results for Q1 2005 included $211,000 of net income from this discontinued segment.
- Management Commentary: Management believes liquidity is satisfactory, with $151.1 million available under the revolving credit facility. The company expects to remain in compliance with all debt covenants.
Investor Verification Checklist
- Medicare Receivables: Verify the timing of the $19.6 million Medicare payment received April 1, 2005, and the status of licenses for recently acquired operations contributing to the accounts receivable increase.
- OIG Investigation Impact: Monitor updates on the Office of Inspector General investigation into VITAS billing practices for potential fines or operational restrictions.
- Debt Covenant Compliance: Confirm continued compliance with financial covenants, particularly as testing begins for the quarter ending June 30, 2005.
- Stock Split Execution: Verify the effective date and share count adjustments following the May 11, 2005 stock split.
- LTIP Expenses: Review future quarters for volatility in compensation expenses related to the Long-Term Incentive Plan performance targets.